Stock listing
NASDAQ:PRNB Principia Biopharma Inc Stock
Follow Principia Biopharma Inc into a list and get an email when it puts out news.
Last close · NASDAQ:PRNB
$100.05 USD
Close on Sep 28, 2020 · No longer trades
- Lowest – highest close
- $22.32 – $101.07 USDSince Sep 14, 2018 · lowest Oct 18, 2018 · highest Aug 25, 2020
Delisted NASDAQ:PRNB no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:PRNB
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Principia Biopharma Inc on 6ix
- Decks
- 1 deck · latest Dec 9, 2019
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Technical Presentation (December 2019) | Technical | 14 slides | Dec 9, 2019 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| John W Smither Other companies: Attovia Therapeutics, Inc. (Director · Since at least Aug 4, 2026); MBX Biosciences, Inc. (Chief Financial Officer · Since at least Mar 16, 2026); NewAmsterdam Pharma Company N.V. (Director · Since at least Dec 29, 2023); Genelux Corporation (Director · Since at least Sep 11, 2023); Applied Molecular Transport Inc (Director · Jan 27, 2022 – Dec 27, 2023 · Past); eFFECTOR Therapeutics Inc (Director · Aug 25, 2020 – Jun 22, 2023 · Past); Arcutis Biotherapeutics, Inc. (Chief Financial Officer · Jan 30, 2020 – Feb 13, 2024 · Past); Achaogen Inc (Director · Mar 11, 2014 – Jun 5, 2018 · Past); Kythera Biopharmaceuticals Inc (Chief Financial Officer · Oct 10, 2012 – Oct 1, 2015 · Past) | Director · Feb 19, 2019 – Feb 19, 2019 · Past |
| Christopher Y Chai Other companies: Surrozen, Inc. (Director · Since at least Aug 11, 2021) | Chief Financial Officer · Sep 13, 2018 – Sep 28, 2020 · Past |
Log in to ask 6ix AI your own questions about Principia Biopharma Inc.